MENOPAUSE METABOLIC SUPPORT STACK
Targeted lipolysis, mitochondrial biogenesis, and functional endocrine equilibrium.
The Menopause Metabolic Support Stack is formulated specifically to address stubborn weight gain, visceral fat accumulation, and de-accelerated cellular energy caused by mid-life hormonal shifts.
- Tesamorelin (10mg)
- AOD9604 (10mg)
- MOTS-C (20mg)
For in vitro use only.
Taxes included. Shipping calculated at checkout.
Included Formulas
1x Tesamorelin Pen (10mg): GHRH analogue that targets visceral abdominal fat stores.
1x AOD9604 Pen (10mg): Lipolytic growth hormone fragment that stimulates fat breakdown without affecting blood sugar.
1x MOTS-C Pen (20mg): Mitochondrial exercise-mimetic peptide that restores cellular energy and glucose balance.
Expected Benefits
By combining clinical research with day-to-day wellness support, this protocol offers clear metabolic improvements:
Visceral Fat Clearance: Targets the stubborn, hard abdominal fat associated with estrogen and endocrine shifts.
Lipolysis Acceleration: Stimulates fat breakdown while preventing new fat cell storage.
Glycaemic & Insulin Stability: Burns fat without triggering blood sugar spikes or altering insulin sensitivity.
Mitochondrial Energy Output: Restores cellular ATP production to clear physical fatigue.
Lean Muscle Preservation: Protects structural muscle tissue during active fat loss cycles.
| Protocol Tier | Duration & Supply | Normal Price | Discounted Price | Total Savings |
|---|---|---|---|---|
| The 4-Week Baseline Stack | 1 Month Supply (3 Pens total) |
£398.00 | £358.10 | Save £39.90 (10% OFF) |
| The 8-Week Intermediate Stack | 2 Month Supply (6 Pens total) |
£796.00 | £676.30 | Save £119.70 (15% OFF) |
| The 12-Week Optimal Renewal Stack | 3 Month Supply (9 Pens total) |
£1,197.00 | £957.60 | Save £239.40 (20% OFF) |
What is the MENOPAUSE METABOLIC SUPPORT STACK?
Mid-life hormonal transitions often cause sudden weight retention around the abdomen that resists standard exercise and dieting. This stack addresses this issue directly: Tesamorelin targets deep visceral abdominal fat, AOD9604 breaks down stored subcutaneous fat, and MOTS-C resets mitochondrial cellular energy output.
Synergistic Cellular Mechanism
Tesamorelin: Binds to GHRH receptors on pituitary cells to trigger natural growth hormone pulses, specifically clearing visceral fat.
AOD9604: Interacts with beta-3 adrenergic receptors on fat cells to stimulate lipolysis and block fat creation.
MOTS-C: Activates AMPK fuel sensors to drive fatty acid oxidation and shuttle glucose into muscle cells.
Evaluation Protocol Schedule
Tesamorelin: 1mg daily (20 clicks once per day before bed).
AOD9604: 250mcg–500mcg daily (5–10 clicks in the morning on an empty stomach).
MOTS-C: 5mg weekly, split into two 2.5mg applications (25 clicks twice per week).
*Once target visceral fat reduction and energy levels are achieved, dosage can be reduced again.*:
Possible Side Effects
Transient Flushing: Mild, brief warming of the face following evening Tesamorelin administration.
Localized Warming: Temporary warmth at injection sites due to local microcirculation stimulation.
Site Pinkness: Minor, transient redness at application points.
Manufactured and tested to
pharmaceutical standards
- Tesamorelin (10mg)
- AOD9604 (10mg)
- MOTS-C (20mg)
For in vitro use only.
Taxes included. Shipping calculated at checkout.